Evidence map›Paper›PMID 41266799›Full record

ArticleScientific reports2025

Host-specificity and therapeutic potential of novel Escherichia coli-targeting bacteriophages for bovine mastitis control.

Jacob Diderich, Céline Antoine, Thomas Cornet, Cédric Toussaint, Marc Saulmont, Thibault Helleputte, Damien Thiry

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jacob DiderichLaboratory of Veterinary Bacteriology, Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, FARAH, University of Liège, Liège, 4000, Belgium.
Céline AntoineLaboratory of Veterinary Bacteriology, Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, FARAH, University of Liège, Liège, 4000, Belgium.
Thomas CornetDNAlytics, Ottignies Louvain-La-Neuve, 1348, Belgium.
Cédric ToussaintDNAlytics, Ottignies Louvain-La-Neuve, 1348, Belgium.
Marc SaulmontRegional Animal Health and Identification Association (ARSIA), Ciney, 5590, Belgium.
Thibault HelleputteDNAlytics, Ottignies Louvain-La-Neuve, 1348, Belgium.
Damien ThiryLaboratory of Veterinary Bacteriology, Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, FARAH, University of Liège, Liège, 4000, Belgium. Damien.Thiry@uliege.be.

Funding

Service Public de Wallonie Vetphage
6 · The paper itself

Abstract

E. coli mastitis is a major production disease in dairy cattle and requires alternative treatments to antibiotics. In this context, phages are of growing interest, but their host specificity remains a challenge in therapy. This study aimed to characterize eight newly isolated phages for the control of E. coli mastitis, to assess their efficacy in milk and to investigate their specificity. Physicochemical characterization of the phages was performed, followed by in vitro stability and lytic activity assays in raw and heat-treated milks. Genome sequencing of phages and bacteria was performed to investigate phage attachment. Phage stability was maintained across physiological pH and temperature ranges, as well as in raw milk. Phage lytic activity demonstrated bacterial decreases below detection level, but regrowth occurred in raw milk after 5 h of incubation with 3/8 phages. A narrow host range was linked to the diversity of the bacterial collection and to the presence of two receptor-binding proteins among Tevenvirinae. Indeed, structural analysis of the proteins revealed a variable region in the long tail fiber and a conserved short tail fiber. In conclusion, phage specificity was mainly associated with the long tail fiber and milk components didn't hinder the efficacy of phages to control bovine mastitis, although resistance should be investigated.

Indexed as

BacteriophagesEscherichia coliEscherichia coli InfectionsHost SpecificityMastitis, BovinePhage TherapyAnimalsCattleFemaleMilkBacteriophageBovine mastitisEscherichia coli (E. coli)Host-specificityMilkReceptor-binding protein

Identifiers

PMID41266799
PMCPMC12635073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.